Trial intelligence / Profile preview

Validation of the Heat-Capsaicin-Warmth neuropathic pain sensitization model using gabapentin and remifentanil

NL-OMON34072Active, not recruiting

Sponsor
Lygature
Start
Jun 2010
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Trial of gabapentin, remifentanil and diazepam in Neuralgia (3 arms), sponsored by Lygature. Primary endpoints: Area of secondary hyperalgesia, Area of tactile allodynia and 4 more. Started Jun 2010; status: active, not recruiting.

02

Drugs

gabapentinremifentanildiazepam
03

Conditions

Neuralgia

Beyond the preview

Go deeper on NL-OMON34072.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON34072.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call